Asparaginase activity monitoring and management of asparaginase hypersensitivity reactions in Canada
M Pike, T MacDonald, K Kulkarni
Meghan Pike, MD
Department of Pediatrics/Division of Pediatric Hematology-Oncology
Dalhousie University/IWK Health Centre
5850/5980 University Avenue
PO Box 9700
Halifax, Nova Scotia
B3K 6R8
phone: (902) 266-2790
fax: (902) 470-7216
meghan.pike@dal.ca
Ketan Kulkarni, MD
Department of Pediatrics/Division of Pediatric Hematology-Oncology
Dalhousie University/IWK Health Centre
5850/5980 University Avenue
PO Box 9700
Halifax, Nova Scotia
B3K 6R8
(902) 470-3795
ketan.kulkarni@iwk.nshealth.ca
Tamara MacDonald, PharmD (Corresponding Author)
Clinical Pharmacy Specialist Hematology/Oncology
Faculties of Medicine and Health Professions,
Dalhousie University/IWK Health Centre
5850/5980 University Avenue
PO Box 9700
Halifax, Nova Scotia
B3K 6R8
(902) 470-6474
tamara.macdonald@iwk.nshealth.ca
WORD COUNT: ABSTRACT: 219 words
WORD COUNT: MAIN TEXT: 2806 words
Number of Tables: 2
Number of Figures : 0
Number of Supporting Information Files: 1
Short Running Title: Asparaginase activity monitoring in Canada
Data Availability Statement: Data available on request from the authors.
Keywords: asparaginase, TDM, acute lymphoblastic leukemia, survey, hypersensitivity, Erwinia